Trials / Completed
CompletedNCT02425423
Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- United Pharmaceuticals · Industry
- Sex
- All
- Age
- 5 Months
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the efficacy of a new thickened formula on regurgitation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | New thickened formula |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-03-01
- Completion
- 2014-06-01
- First posted
- 2015-04-24
- Last updated
- 2015-04-24
Locations
3 sites across 2 countries: Belgium, France
Source: ClinicalTrials.gov record NCT02425423. Inclusion in this directory is not an endorsement.